PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
*To whom correspondence should be addressed. E-mail: firstname.lastname@example.org
Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
Post a new comment
on this article